Friday, May 23, 2025
UG Standard - Latest News
  • Home
  • News
    • DIPLOMACY
    • COURT
    • AFRICA
    • BOOK REVIEW
    • INTERVIEW:
    • National
    • Parliament
    • World
    • Regional
  • Business
    • AGRIBUSINESS
    • OIL & GAS
    • REAL ESTATE
    • TECH
    • INNOVATIONS
    • TELCOM
  • OpED
  • EDUCATION
  • INVESTIGATION
    • NATIONAL ARCHIVE
    • SPECIAL REPORT
    • ANALYSIS
  • FEATURES
    • SOCIETY
    • Community
    • Pictorial
    • PROFILES
    • Lifestyle
    • Health
    • ENVIRONMENT
  • Tours & Travel
    • Hotel & Hospitality
  • Sports
  • About Us
  • Login
UG Standard - Latest News
Your browser does not support the video tag.
ADVERTISEMENT

Dei Biopharma gets NDA clearance for drugs manufacturing

by LILIAN MUWONGE | UG STANDARD REPORTER
13/05/2024
in News
Reading Time: 2 mins read
A A
0
Share on FacebookShare on Twitter
Dei Biopharm’s state-of-the-art vaccine manufacturing facility has received prestigious NDA accreditation, marking a significant milestone in the company’s commitment to delivering high-quality vaccines and contributing to the advancement of public health in Uganda and beyond

KAMPALA, UGANDA – Dei Biopharma Limited has been granted a landmark license by the National Drug Authority (NDA) to manufacture drugs at its premises in Matugga. This certification marks a major achievement for the company, allowing it to produce essential drugs, including Hard Gelatin Capsules and Tablets, among other product categories in different dosage forms.

The NDA issued two certificates to Dei Biopharma Limited, authorizing the company to manufacture drugs and confirming the suitability of its premises for drug manufacturing.

Related posts

Amb. Milton Kambula, President Global Peace Foundation (GPF)

2026 Elections: Amb. Kambula urges Ugandans to Desistfrom Political, Tribal Divisions

20/05/2025
165
Deputy Chief Justice Dr. Flavian Zeija being welcomed by Acting Chief Registrar, Pamella Lamunu and Judiciary Public Relations Officer, Eremye Mawanda on Thursday.

Judiciary extends service closer to people on Buvuma Court open day

18/05/2025
167
The acused in dock on Friday. (Courtesy photo)

Advocate charged and remanded over Forgery

17/05/2025
270
The Head of the Anti-Corruption Unit at State House, Brig. Gen. Henry Isoke

Brigadier Isoke urges Police officers to Spearhead the fight against Corruption

14/05/2025
1.4k

The certificates, issued under the National Drug Policy and Authority Regulations 2014, validate the company’s compliance with the required standards and regulations.

Dei Biopharm's modern and well-equipped facility, with a team of professionals in the background, working diligently to produce life-saving vaccines
Dei Biopharm’s modern and well-equipped facility, with a team of professionals in the background, working diligently to produce life-saving vaccines

The first certificate, numbered NDA/PRE/PMC/11331, certifies that Dei Biopharma Limited’s premises at Block 82, Plot 988-990 & 3325-3326 Kigoogwa, Bombo Road, Uganda, are suitable for drug manufacturing.

The second certificate authorizes the company to manufacture finished pharmaceutical products, including Non-Beta Lactam (Human) tablets and Hard Gelatin Capsules.

Dr. Matthias Magoola, the founder and Chief Executive Officer of Dei Group of Companies, thanked President Museveni for supporting Ugandan scientists and innovation, contributing to the company’s achievements, including the development of the first biotech facility in Africa.

With a 150-acre facility, Dei Biopharma Limited is poised to manufacture a wide range of essential drugs, including vaccines, biological solutions, and cancer treatments. The facility has already received a significant investment of over USD 500 million and is expected to cost USD 1.1 billion upon completion.

The facility boasts a biotech facility, the first in Africa under US patent, which will produce the latest cancer drugs, biosimilars, peptides, cell therapy, biologics, cytokines, therapeutic proteins, gene therapy, and vaccines, including mRNA and others. The facility is fully compliant with FDA, EU-EMA, and WHO standards, ensuring the production of high-quality drugs and vaccines.

Vaccine innovation meets excellence! Dei Biopharm's state-of-the-art facility receives NDA accreditation, cementing its commitment to quality and safety.
Vaccine innovation meets excellence! Dei Biopharm’s state-of-the-art facility receives NDA accreditation, cementing its commitment to quality and safety.

The company’s injectable facility, 80% complete, will manufacture vital drugs, including Filgrastim, Erythropoietin, and Trastuzumab. The facility also features a massive warehousing facility, complete with cutting-edge cold chain technology, capable of storing 60,000 pallets of mRNA and other vaccines, as well as other pharmaceutical products.

The YKTM (Yoweri Kaguta Tibuhaburwa Museveni) GLP Biotech Laboratories, a crucial component of the facility, include components for cancer research, QA/QC, drug discovery, gene therapy, cell therapy, mRNA therapeutics, vaccines, biosimilars, and biologics. The generic section will manufacture over 150 different drugs and medicines, while the state-of-the-art nutraceuticals section will produce tablets, capsules, sachets, ointments, and syrups.

The penicillin, cephalosporin, and non-beta lactam facility, designed to meet the most stringent FDA, WHO, and EU-EMA guidelines, will be completed next year. The oncology/cancer manufacturing facility, designed to meet FDA standards under EOL5 guidelines and technology, will also be completed soon.

Furthermore, the virus vaccines facility, expected to be completed next year, will produce a range of vaccines, including tetanus toxoid, tetanus diphtheria, hepatitis B, DTP-Hep B-Hib, TIV/QIV, PCV 10, TCV, COVID-19, and HPV bivalent vaccines.

Share this:

  • Share
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on X (Opens in new window) X
  • Click to share on Pinterest (Opens in new window) Pinterest
  • Click to share on Telegram (Opens in new window) Telegram
  • Click to share on WhatsApp (Opens in new window) WhatsApp

Like this:

Like Loading...

Related

Tags: Dei Biopharm Vaccines facilityDei Biopharm Vaccines Plant seeks UGX 1.8 trillion from governmentFeaturedMatthias Magoola

Related Posts

 Abbas urges U.S. to compel Israel to stop violations against Palestinians
News

 Abbas urges U.S. to compel Israel to stop violations against Palestinians

05/11/2022
0
236

Abbas urges U.S. to compel Israel to stop violations against Palestinians RAMALLAH, Nov. 4 (Xinhua) -- Palestinian President Mahmoud Abbas...

Read moreDetails
Equity ranked 4th strongest banking brand globally on brand strength, scoring 92.4 points out of 100

 Equity Bank Under Scrutiny for Alleged Role in UGX.3bn Fake Gold Scam

09/07/2024
532
Kabuleta and other opposition politicians have teamed up to put an end to Museveni's leadership

 Kabuleta, other opposition politicians team up to put an end to Museveni’s leadership

27/02/2024
394
President Museveni

 Museveni commends Ugandan scientists! 

21/07/2020
855
Load More

Popular Articles

  • Check out the top schools with pupils who scored 6 in 4 aggregates in the 2024 PLE results, as released by UNEB

    PLE 2024 Results: Top Schools with 6 in 4 Aggregates

    4301 shares
    Share 1720 Tweet 1075
  • NIRA unveils high-tech National ID, mass enrollment set to begin

    2590 shares
    Share 1036 Tweet 648
  • FULL LIST: Ministry of Education, NCDC publish self-study workbooks amid COVID-19 lockdown

    3318 shares
    Share 1346 Tweet 822
  • How to Check PLE Results 2024 on Phone, Online

    1776 shares
    Share 710 Tweet 444
  • PLE 2024 Results: UNEB Clarifies on Release Date

    1647 shares
    Share 659 Tweet 412
  • MPs clear govt to cancel 2020 academic year

    2795 shares
    Share 1149 Tweet 686
  • UNEB agrees to adjust examinations timetables to accommodate lost time

    2660 shares
    Share 1086 Tweet 656

Recent Articles

D/ASP Charles Twine (in army green jacket) with Noah Mutwe arriving at Buganda Road court on Thursday.

TREASON? Ex-CID Boss Busted for Threatening Museveni, Muhoozi!

23/05/2025
Gen. Salim Saleh, a key presidential advisor, meets with European Union officials, including Ambassador Jan Sadek in Gulu, Uganda, calling for a "political ceasefire" and inter-party dialogue ahead of the 2026 general election.

Gen. Saleh addresses EU concerns over CDF Muhoozi’s tweets

23/05/2025
Uganda's Education Ministry has issued strict new guidelines banning extravagant school parties, luxury transport, and lavish election campaigns. The move aims to restore discipline and curb excessive displays of wealth, with headteachers facing disciplinary action for non-compliance.

Education ministry bans cars, couples, choppers and lavish parties in schools

23/05/2025

aBi Finance, UIBFS Equip Lenders for Climate Challenges

23/05/2025
Tree-climbing lions in Ishasha, are one of the wildlife attractions unique to Uganda and a few other countries on the African continent. With proper investment in marketing the destination

UK travel advisories hurt Uganda park tourism

23/05/2025

Whistleblower Alleges Widespread Judicial Fraud in Uganda Courts

23/05/2025
Senior Superintendent of Police Nixon Agasirwe

Ex-Uganda Police Commander Nixon Agasirwe Arrested in 2015 Prosecutor Murder

23/05/2025

Recent CommentsRecent Comments

  • Parliamentary Committee Grills Local Government Over PDM Funds, Accountability – Press Uganda on Parliamentary committee grills local government over PDM funds, accountability
  • Uganda Faces Billions In Tax Losses From Thriving Illicit Alcohol Trade – Press Uganda on Uganda Faces Billions in Tax Losses from Thriving Illicit Alcohol Trade
  • CAUGHT RED-HANDED?! Top Kampala Lawyer-Lender Faces Claims Of Courtroom Manipulation And “Phantom Documents”! – Press Uganda on CAUGHT RED-HANDED?! Top Kampala Lawyer-Lender Faces Claims of Courtroom Manipulation and “Phantom Documents”!
  • Centenary Bank Boss: Startups Should Leverage TikTok For Growth – Press Uganda on Centenary Bank boss: Startups Should Leverage TikTok for Growth
  • 3 Dead, 9 Injured In Mukono Highway Crash – Press Uganda on 3 Dead, 9 Injured in Mukono Highway Crash
UG Standard - Latest News

UG Standard, published via www.ugstandard.com isa publication of Sahel Media Solutions Ltd, a professional Digital/New Media company in Uganda info@ugstandard.com

Follow us on social media:

Latest News

  • TREASON? Ex-CID Boss Busted for Threatening Museveni, Muhoozi!
  • Gen. Saleh addresses EU concerns over CDF Muhoozi’s tweets
  • Education ministry bans cars, couples, choppers and lavish parties in schools
  • aBi Finance, UIBFS Equip Lenders for Climate Challenges
  • UK travel advisories hurt Uganda park tourism
  • Whistleblower Alleges Widespread Judicial Fraud in Uganda Courts

OpED

Understanding Air Expansion and Its Impact in Kasese District, Western Uganda

The Empire, the Spectacle, and the Soft Coup in South Africa

Inside South Africa’s Retail Shake-Up

Afrikaners for the U.S. as Refugees?

In Memoriam: Rajiv Ruparelia – A Legacy of Vision and Heart

© 2024 Ugstandard - Latest News by Digital/New Media company.

Welcome Back!

Sign In with Facebook
OR

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • News
    • DIPLOMACY
    • COURT
    • AFRICA
    • BOOK REVIEW
    • INTERVIEW:
    • National
    • Parliament
    • World
    • Regional
  • Business
    • AGRIBUSINESS
    • OIL & GAS
    • REAL ESTATE
    • TECH
    • INNOVATIONS
    • TELCOM
  • OpED
  • EDUCATION
  • INVESTIGATION
    • NATIONAL ARCHIVE
    • SPECIAL REPORT
    • ANALYSIS
  • FEATURES
    • SOCIETY
    • Community
    • Pictorial
    • PROFILES
    • Lifestyle
    • Health
    • ENVIRONMENT
  • Tours & Travel
    • Hotel & Hospitality
  • Sports
  • About Us

© 2024 Ugstandard - Latest News by Digital/New Media company.

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.
%d